Literature DB >> 21094361

Cardiovascular risk in patients with fasting blood glucose levels within normal range.

David Pereg1, Avishay Elis, Yoram Neuman, Morris Mosseri, Michael Lishner, Doron Hermoni.   

Abstract

Fasting glucose levels elevated beyond the normal range have been associated with increased cardiovascular risk. However, it is unknown whether this association exists for variations of fasting glucose within the normal range. The present study was conducted using the computerized database of the Sharon-Shomron District of Clalit Health Services. Included in the present study were subjects with fasting glucose levels within the normal range (< 100 mg/dl). We excluded patients with a history of cardiovascular disease or diabetes. The primary outcome was the incidence of coronary revascularization with either percutaneous coronary intervention or coronary artery bypass grafting. The 28,263 participants (age 53.7 ± 12.2 years) were divided into quartiles according to the fasting glucose level (75.4 ± 4.5, 83.6 ± 1.7, 88.9 ± 1.4, and 95.1 ± 2.2 mg/dl). During a mean follow-up of 5.9 ± 0.7 years, 424 subjects required coronary revascularization. A progressive increase was seen in the risk of coronary revascularization as the fasting glucose levels increased within the normal range (hazard ratio 1.73, 95% confidence interval 1.3 to 2.3, p > 0.001, between the fourth and first quartiles). However, this association lost its statistical significance after adjustments for the conventional coronary risk factors (hazard ratio 1.17, 95% confidence interval 0.85 to 1.62, p = 0.328). In conclusion, elevated fasting glucose levels within the normal range were associated with an increased cardiovascular risk. This association was caused by the greater prevalence of the other conventional risk factors and not by the glucose level itself.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094361     DOI: 10.1016/j.amjcard.2010.07.036

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.

Authors:  C-L Huang; H-W Chang; J-B Chang; J-H Chen; J-D Lin; C-Z Wu; D Pei; Y-J Hung; C-H Lee; Y-L Chen; C-H Hsieh
Journal:  QJM       Date:  2015-11-16

Review 2.  The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.

Authors:  Mark Houston
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01-10

3.  Fasting glucose levels within the high normal range predict cardiovascular outcome.

Authors:  Kivity Shaye; Tirosh Amir; Segev Shlomo; Sidi Yechezkel
Journal:  Am Heart J       Date:  2012-07       Impact factor: 4.749

4.  A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels.

Authors:  Sven Schinner; Reiner Füth; Kerstin Kempf; Stephan Martin; Holger S Willenberg; Matthias Schott; Wilfried Dinh; Werner A Scherbaum; Mark Lankisch
Journal:  Cardiovasc Diabetol       Date:  2011-06-24       Impact factor: 9.951

5.  Glucose and fluoxetine induce fine structural change in human serum albumin.

Authors:  Minoo Shahani; Fatemeh Daneshi-Mehr; Roya Tadayon; Behrooz Hoseinzade Salavati; Ali-Reza Akbar Zadeh-Baghban; Abbas Zamanian; Mostafa Rezaei-Tavirani
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

6.  Pre-impaired fasting glucose state is a risk factor for endothelial dysfunction: Flow-mediated Dilation Japan (FMD-J) study.

Authors:  Takayuki Yamaji; Takahiro Harada; Yu Hashimoto; Yuji Takaeko; Masato Kajikawa; Yasuki Kihara; Eisuke Hida; Kazuaki Chayama; Chikara Goto; Yiming Han; Farina Mohamad Yusoff; Shinji Kishimoto; Tatsuya Maruhashi; Ayumu Nakashima; Yukihito Higashi
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.